Differential effects of lipids on the risk of heart failure and coronary heart disease: The Physicians' Health Study

American Heart Journal

Volumn 155, Issue 5, 2008, Pages 869-875

  Dhingra, Ravi ^a,b,c   Sesso, Howard D ^b,d   Kenchaiah, Satish ^a,b,e   Gaziano, J Michael ^a,b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Alice Peck Day Memorial Hospital   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; HEALTH SURVEYS; HEART FAILURE; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; RISK FACTORS;

EID: 42749088410     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.12.023     Document Type: Article

References (37)

1. American Heart Association. Heart disease and stroke statistics-2005 Update (2005), American Heart Association, Dallas (TX)
2. Hurst W. The heart, arteries and veins. 10th ed. (2001), McGraw-Hill, New York (NY)
3. Kenchaiah S., Narula J., and Vasan R.S. Risk factors for heart failure. Med Clin North Am 88 (2004) 1145-1172
4. Kenchaiah S., Gaziano J.M., and Vasan R.S. Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am 88 (2004) 1273-1294
5. Kannel W.B., D'Agostino R.B., Silbershatz H., et al. Profile for estimating risk of heart failure. Arch Intern Med 159 (1999) 1197-1204
6. Huang Y., Walker K.E., Hanley F., et al. Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet. Circulation 109 (2004) 97-102
7. Jullien V., Gosse P., Ansoborlo P., et al. Relationship between left ventricular mass and serum cholesterol level in the untreated hypertensive. J Hypertens 16 (1998) 1043-1047
8. Sundstrom J., Lind L., Vessby B., et al. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 103 (2001) 836-841
9. Horio T., Miyazato J., Kamide K., et al. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens 16 (2003) 938-944
10. Kannel W.B., and Belanger A.J. Epidemiology of heart failure. Am Heart J 121 (1991) 951-957
11. Ho K.K., Pinsky J.L., Kannel W.B., et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 (1993) 6A-13A
12. Wilhelmsen L., Rosengren A., Eriksson H., et al. Heart failure in the general population of men-morbidity, risk factors and prognosis. J Intern Med 249 (2001) 253-261
13. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
14. Ingelsson E., Sundstrom J., Arnlov J., et al. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
15. Horwich T.B., MacLellan W.R., and Fonarow G.C. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 43 (2004) 642-648
16. Aronow W.S., and Ahn C. Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol 90 (2002) 147-149
17. Kjekshus J., Pedersen T.R., Olsson A.G., et al. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 3 (1997) 249-254
18. Vaughan C.J., Murphy M.B., and Buckley B.M. Statins do more than just lower cholesterol. Lancet 348 (1996) 1079-1082
19. Stampfer M.J., Buring J.E., Willett W., et al. The 2 × 2 factorial design: Its application to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med 4 (1985) 111-116
20. Christen W.G., Gaziano J.M., and Hennekens C.H. Design of Physicians' Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 10 (2000) 125-134
21. Lipid research clinics programs: manual of laboratory operations vol 1. Lipid and lipoprotein analysis (1974), DHEW Government Printing Office, Washington (DC) Report No. NIH 75-628
22. Djousse L., and Gaziano J.M. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 115 (2007) 34-39
23. McKee P.A., Castelli W.P., McNamara P.M., et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1441-1446
24. World Health Organization. Ischaemic heart disease registers: report of the Fifth Working Group, including a second revision of the operating protocol (1971), World Health Organization, Copenhagen, Denmark
25. SAS Institute Inc. SAS/STAT user's guide, version 6.12 (1997), SAS Institute Inc, Cary (NC) 871-948
26. Eriksson H., Svardsudd K., Larsson B., et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 10 (1989) 647-656
27. Lewis E.F., Moye L.A., Rouleau J.L., et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: The CARE study. J Am Coll Cardiol 42 (2003) 1446-1453
28. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
29. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
30. Conraads V.M., Bosmans J.M., Schuerwegh A.J., et al. Association of lipoproteins with cytokines and cytokine receptors in heart failure patients: differences between ischaemic versus idiopathic cardiomyopathy. Eur Heart J 24 (2003) 2221-2226
31. Christ M., Klima T., Grimm W., et al. Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J 27 (2006) 691-696 [Electronic publication 2005 Apr. 8]
32. Fujii N., Nozawa T., Igawa A., et al. Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H760-H766
33. Lefer D.J. Statins as potent antiinflammatory drugs. Circulation 106 (2002) 2041-2042
34. Sola S., Mir M.Q., Lerakis S., et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 47 (2006) 332-337
35. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) 10-38
36. Go A.S., Lee W.Y., Yang J., et al. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 296 (2006) 2105-2111
37. Carroll M.D., Lacher D.A., Sorlie P.D., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294 (2005) 1773-1781